EAM
ELVN icon

Exome Asset Management’s Enliven Therapeutics ELVN Stock Holding History

Exome Asset Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-57,635
Closed -$1.01M – 59
2024
Q1 		$1.01M Buy
+57,635
New +$1.01M 0.87% 46